SERA - Sera Prognostics Inc logo

Sera Prognostics Inc

SERA

Sera Prognostics develops and commercializes blood-based biomarker tests and predictive analytics for women's health, focusing on pregnancy-related conditions. Their flagship product, the PreTRM test, assesses premature birth risk in expectant mothers.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$196today

Score Overview

1 Year
Score
Net Growth-4.09%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-13.58%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.8
Net Growth5.07%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-14.63%
Rev Trend60%
Revenue Consistencyโ€”
All Time
Score
Net Growth5.07%
Net Trend60%
Net Income Consistency
Rev Growth-14.63%
Rev Trend60%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Sera Prognostics Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. SERA does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 2.03โ€”
1 Year2025-10-23
$ 3.35-39.40%
5 Years2021-10-22
$ 10.34-80.37%
All Time2021-07-15
$ 11.90-82.94%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 70K-$ 33M$ 46M
2025$ 81K-$ 31M$ 39M
2024$ 77K-$ 32M$ 46M
2023$ 306K-$ 36M$ 49M
2022$ 268K-$ 44M$ 82M
IPO2021$ 82K-$ 35M$ 105M
SERA - Sera Prognostics Inc logo

Sera Prognostics Inc fundamental performance

Between 2021 and 2025, revenue declined from $ 82K to $ 81K and net income went from -$ 35M to -$ 31M. Revenue increased in 60% of the years measured; net income in 60%.

Sera Prognostics Inc currently holds a 5-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.

Membership

Explore SERA with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies